Hormone therapy explored for aggressive brain tumor
NCT ID NCT05091866
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tested whether natural progesterone, a hormone normally involved in pregnancy, could help control recurrent glioblastoma (a fast-growing brain cancer). Four adults whose cancer had returned after standard treatments received daily progesterone injections under the skin. The goal was to find the right dose, check safety, and see if it could slow tumor growth. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOSARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Radioactive beads take aim at brain tumours
- Two-Drug combo aims to outsmart recurrent brain tumors
- Gene-Edited immune cells take on aggressive brain tumors
- Targeted radiation delivered directly to brain tumor cavity in new trial
- Experimental trio therapy takes on recurrent glioblastoma
- Immunotherapy drug nivolumab tested in young brain cancer patients